Urological Sarcoma Among the Iranian Population; A National Registry-Based Study

• Published in: International Journal of Cancer Management Vol. 13; no. 12
• Main Authors: Ganji Jameshouran, Mohammad Ali, Allameh, Farzad, Mansouri Tehrani, Mohammad Mersad, Tasharrofi, Mohammad Ali, Javanmard, Babak, Fallah Karkan, Morteza, Akbari, Mohammad Esmaeil
• Format: Journal Article
• Language: English
• Published: 01.12.2020
• ISSN: 2538-4422; 2538-497X
• DOI: 10.5812/ijcm.103700

Background: Sarcomas of the genitourinary tract are rare clinical entities with relatively few studies conducted on their prevalence and characteristics globally. Previous literature has established the effects of ethnicity and race on soft tissue sarcomas’ clinical attributes and prognosis. Objectives: To provide researchers and clinicians with a better understanding of the matter, this study aims at providing descriptive data regarding urologic sarcoma among the Iranian population. Methods: All patients diagnosed with genitourinary sarcoma registered in the Cancer Research Center (CRC) between 2009 and 2014 were enrolled in this national population-based study. Basic patient data including their gender, age, city, and province of origin, as well as each patient’s tumor characteristics were retrieved from CRC’s database. Chi-square test was utilized in determining a possible relationship between patient data and the tumor characteristics. Results: A total of 337 patients with primary genitourinary sarcoma were selected for this study. More than half of the patients were classified in the 15 to 65-year-old group. The most common primary site of involvement was the kidneys with the most prevalent histological subtype being liposarcoma. Conclusions: This study found sarcomas of the genitourinary tract to be more prevalent among the adult Iranian population, with liposarcoma, leiomyosarcoma, and rhabdomyosarcoma being the most commonly observed subtype, and factors such as age, gender, and tumor grading all related to the anatomical distribution of the tumors.